Our data with markedly increased levels of mtROS in CGD cells are not in agreement with a previous publication by Fernandez-Boyanapalli et al. that reported partial reversal of ROS production in CGD cells upon treatment with the PPARγ agonist pioglitazone (34). The gene discussed is PPARG; the disease is chronic granulomatous disease.